Through a recent notice, the National Pharmaceutical Pricing Authority (NPPA) has granted a five-year exemption from price ...

Nikki Palleja spent last Thursday night on the terrace of her dorm positioned next to a model of the human brain. She was flagging down fellow students to ...

PALI-2108 demonstrated favorable safety and tolerability with no serious adverse events after two weeks of treatment in a difficult-to-treat ...

A precision cancer strategy that selectively kills tumour cells while leaving healthy tissue intact may be within reach for the majority of colorectal cancer patients, according to new research ...

Connect Biopharma (NASDAQ:CNTB) shared new clinical and preclinical updates on rademikibart, its IL-4 receptor alpha ...

Nuclera, the biotechnology company enabling rapid access to high-quality proteins, today announced the launch of its nanodisc ...

Alzheimer’s disease (AD) and related dementias (ADRD) remain major unmet medical needs, in part because disease mechanisms span multiple interacting ...

Written FDA recommendations include a second Phase 3 trial to generate additional efficacy and safety data prior to NDA submission of ...

OpenAI’s ChatGPT models have shown a sharp jump in accuracy on a high-stakes medical licensing exam, with newer versions ...

Hokkaido University (HU) and the University of Melbourne (UoM) have maintained a research partnership for more than half a century, particularly in ...

India, March 30 -- Monash University has strengthened its position as one of the world's leading research and education institutions, with outstanding results across all faculties in the 2026 QS World ...

On the surface, it wasn't obvious to anyone that Emma Griffiths was drinking more than ten bottles of wine a week.